Technology

Oxylus Energy Raises $4.5 Million Seed Round for Clean Fuel Technology

Published

2 years ago

September 3, 2024

Toyota Ventures and Azolla Ventures Investments will Boost Development of Cost-Effective Green Methanol Production

NEW HAVEN, Conn., Sept. 3, 2024 /PRNewswire/ — Oxylus Energy, developer of a novel carbon utilization technology for the production of e-fuels, today announced the close of its $4.5 million Series Seed investment co-led by Toyota Ventures and Azolla Ventures with participation from Earth Foundry and Connecticut Innovations. Oxylus’ solution is the first low-temperature and low-pressure conversion of carbon dioxide to green methanol, a liquid fuel. This is enabled by commercializing the first-ever catalyst developed at Yale University by Professor Hailiang Wang for direct electrochemical conversion of carbon dioxide to methanol. Building reactors similar to green hydrogen electrolyzers, Oxylus creates methanol using only captured carbon dioxide, water and electricity. Designed to operate in modular conditions, this approach is a lower-cost technology for carbon conversion into alternative fuels. This funding will accelerate Oxylus’ technology development, prototype testing and pilot deployment.

Oxylus Energy’s methanol can be used as a drop-in fuel replacement or upgraded to jet fuel and other green petrochemicals. By uniquely combining carbon conversion and alternative fuel production this approach can reduce energy expenditures and cut costs for fuel production. “Direct electrochemical conversion of carbon dioxide at low temperatures and pressures is the only way to decrease the cost of green methanol,” said Conor Rooney, Co-Founder and CTO of Oxylus. According to Harrison Meyer, Co-Founder and COO of Oxylus, “Without decreasing the price of methanol it will be difficult to decarbonize the hard-to-abate sectors of aviation, shipping, and petrochemicals that are currently responsible for 11% of global emissions.”

The World Economic Forum states that green methanol can reduce carbon dioxide emissions by almost 95%. Furthermore, “green methanol can be blended with traditional gasoline or diesel fuel, offering a seamless transition … minimizing the need for infrastructure upgrades.” Current green methanol production is less than 0.2 million tons annually, but according to estimates from the International Renewable Energy Agency (IRENA), this is likely to rise to 500 million tons by 2050. “This is why Oxylus’ technology is critical—it can meet the growing market demand for methanol in the net-zero transition at a price that actually works for industry,” said Co-Founder and CEO Perry Bakas.

“We are thrilled to support the team at Oxylus Energy as they work to scale this cost-effective process for e-fuel production,” said Lisa Coca, Climate Fund partner, Toyota Ventures. “Eliminating the need for hydrogen as an input is a significant innovation in the green energy space that has the potential to dramatically reduce production costs and unlock numerous decarbonization pathways.”

“While green methanol provides a pathway to decarbonize hard-to-abate sectors like shipping, maritime and aviation, price premiums and limited supply restrict feasibility of adoption. Oxylus Energy’s modular single-step CO2 electrolyzer, however, is highly efficient, reduces cost, and can be easily stacked to scale green methanol production,” said Amy Duffuor, General Partner at Azolla Ventures. “Oxylus Energy’s technical progress combined with the novel catalyst, complementary team and ability to target multiple market applications, makes it an optimal investment for Azolla. We are incredibly excited to partner with Oxylus Energy on the next phase of their journey.”

About Oxylus Energy
Oxylus Energy is a climate technology company developing low-temperature and low-pressure conversion of carbon dioxide into green methanol. Oxylus Energy was founded at Yale by graduate students Harrison Meyer, Conor Rooney, and Perry Bakas and incubated at ClimateHaven. Oxylus Energy converts CO2 into carbon-neutral fuels and chemical feedstocks. Oxylus’ electrolyzers are designed to be modular and enable onsite carbon utilization and fuel production. Carbon utilization in green methanol can provide drop-in fuels and chemical feedstocks for the hard-to-abate sectors of shipping, aviation, and petrochemicals. To learn more, go to: https://www.oxylusenergy.com/

About Toyota Ventures
Toyota Ventures is the early-stage venture capital arm of Toyota. Founded in July 2017, its mission is to discover what’s next for Toyota by helping startups bring disruptive technologies and business models to market quickly. With more than $800 million in assets under management, the firm is dedicated to investing in talented entrepreneurs around the world who are driving innovation in frontier technologies and climate solutions. For more information about Toyota Ventures and its portfolio companies, please visit www.toyota.ventures.

About Azolla Ventures
Azolla Ventures, launched by Prime Coalition in 2021, is an early-stage investor in climate breakthroughs that could avert catastrophic climate change. At Azolla Ventures, we prioritize impact first: every investment holds the potential for large-scale greenhouse gas reductions and a more just climate for all. The team seeks out bold entrepreneurs from all corners and embraces opportunities outside of venture norms. Azolla Ventures manages the $239MM Azolla Fund I and the $50MM Prime Impact Fund. For more information about Azolla Ventures, please visit https://www.azollaventures.com

Media Contact:
Victoria Reich
Mahoney Communications Group
382663@email4pr.com
212-220-6045

View original content:https://www.prnewswire.com/news-releases/oxylus-energy-raises-4-5-million-seed-round-for-clean-fuel-technology-302237086.html

SOURCE Oxylus Energy

Technology

MATSON ANNOUNCES ADDITION OF 3 MILLION SHARES TO EXISTING SHARE REPURCHASE PROGRAM AND QUARTERLY DIVIDEND OF $0.36 PER SHARE

Published

51 seconds ago

April 23, 2026

HONOLULU, April 23, 2026 /PRNewswire/ — The Board of Directors of Matson, Inc. (NYSE: MATX), a leading U.S. carrier in the Pacific, approved adding three million shares to its existing share repurchase program and extending the program to December 31, 2029. As of April 23, 2026, the existing share repurchase program had approximately 0.7 million shares remaining. The Board also declared a second quarter dividend of $0.36 per common share. The dividend will be paid on June 4, 2026 to all shareholders of record as of the close of business on May 7, 2026.

“We are pleased to announce an additional three million shares to our existing share repurchase program,” said Matt Cox, Matson’s Chairman and Chief Executive Officer. “Since we commenced our share repurchase program in August 2021, we have repurchased approximately 14.3 million shares, or approximately 33% of the then outstanding shares, for a total cost of $1.3 billion. Going forward, we will continue to be both disciplined and opportunistic in our capital allocation, and we remain committed to returning excess cash to shareholders to create additional shareholder value over the long-term.”

Shares will be repurchased in the open market from time to time at the Company’s discretion, based on ongoing assessments of the capital needs of the business, the market price of its common shares and general market conditions. The Company may enter into Rule 10b5-1 plans to facilitate purchases under the program. The repurchase program may be suspended or discontinued at any time.

About the Company

Founded in 1882, Matson (NYSE: MATX) is a leading provider of ocean transportation and logistics services. Matson provides a vital lifeline of ocean freight transportation services to the domestic non-contiguous economies of Hawaii, Alaska, and Guam, and to other island economies in Micronesia. Matson also operates premium, expedited services from China to Long Beach, California, which includes cargo from other Asia origins, provides services to Okinawa, Japan and various islands in the South Pacific, and operates an international export service from Alaska to Asia. The Company’s fleet of owned and chartered vessels includes containerships, combination container and roll-on/roll-off ships and barges. Matson Logistics, established in 1987, extends the geographic reach of Matson’s transportation network throughout North America and Asia. Its integrated logistics services include rail intermodal, highway brokerage, warehousing, freight consolidation, supply chain management, and freight forwarding to Alaska. Additional information about the Company is available at www.matson.com.

Forward Looking Statements

Statements in this news release that are not historical facts are “forward-looking statements,” within the meaning of the Private Securities Litigation Reform Act of 1995, that involve a number of risks and uncertainties that could cause actual results to differ materially from those contemplated by the relevant forward-looking statement, including but not limited to, statements about capital allocation plans, the timing, manner and volume of repurchases of common shares pursuant to the repurchase program, and use of excess cash. These forward-looking statements are not guarantees of future performance. This release should be read in conjunction with our Annual Report on Form 10-K and our other filings with the SEC through the date of this release, which identify important factors that could affect the forward-looking statements in this release. We do not undertake any obligation to update our forward-looking statements.

View original content to download multimedia:https://www.prnewswire.com/news-releases/matson-announces-addition-of-3-million-shares-to-existing-share-repurchase-program-and-quarterly-dividend-of-0-36-per-share-302752377.html

SOURCE Matson, Inc.

Technology

Accord Specialty Pharmacy Named Finalist in MMIT’s 11th Annual Retail Specialty Pharmacy Patient Choice Awards

Published

1 hour ago

April 23, 2026

ORLANDO, Fla., April 23, 2026 /PRNewswire/ — Accord Specialty Pharmacy, an independent specialty pharmacy serving patients across multiple states, has been named a finalist in the MMIT Patient Choice Awards, a recognition based on patient-reported satisfaction and experience.

Accord was selected as the only independent pharmacy among finalists in its category, alongside national pharmacy organizations such as Walgreens Specialty Pharmacy and Walmart Specialty Pharmacy. This distinction highlights the company’s commitment to delivering personalized, high-touch care for patients managing complex and chronic conditions.

The MMIT Patient Choice Awards recognize specialty pharmacies that demonstrate excellence in patient satisfaction, service quality, and overall care experience. Finalists are determined based on direct patient feedback, making the recognition a meaningful reflection of the trust patients place in their pharmacy providers.

“Being recognized alongside national organizations and as the only independent finalist validates our belief that personalized, patient-centered care drives better outcomes. We are building a model that combines clinical depth, national reach, and operational flexibility to better serve patients, providers, and partners.” said AJ Patel, Founder and Pharmacy Manager of Accord Specialty Pharmacy.

Accord Specialty Pharmacy supports patients across complex specialty categories, including oncology, rare disease, and infusion, through a clinically driven, high-touch care model designed to improve access, adherence, and outcomes. The company’s approach emphasizes personalized support, responsive care coordination, and strong clinical engagement to help patients navigate complex therapies more effectively. With a growing national footprint and multi-state licensure, Accord is positioned to support patients, providers, and partners across diverse markets.

For more information, visit MMIT Announces Finalists of the 11th Specialty Pharmacy Patient Choice Awards – MMITNetwork.

About Accord Specialty Pharmacy:

Accord Specialty Pharmacy is an ACHC-accredited, multi-state licensed independent specialty pharmacy located in Central Florida, dedicated to delivering high-quality, patient-centered care for individuals managing complex and chronic conditions. Through personalized support, clinical expertise, and a high-touch approach, Accord helps patients navigate every step of their treatment journey. Learn more at www.accordspecialty.com.

CONTACT: contact@accordspecialty.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/accord-specialty-pharmacy-named-finalist-in-mmits-11th-annual-retail-specialty-pharmacy-patient-choice-awards-302752327.html

SOURCE Accord Specialty

Technology

HAIVISION ANNOUNCES VOTING RESULTS FROM 2026 ANNUAL MEETING OF SHAREHOLDERS

Published

1 hour ago

April 23, 2026

MONTRÉAL, April 23, 2026 /CNW/ – Haivision Systems Inc. (“Haivision” or the “Company”) (TSX: HAI) is pleased to announce the voting results from its annual meeting of shareholders held today in a virtual format.

A total of approximately 45.97 % of the issued and outstanding common shares of Haivision were represented at the meeting.

Election of Directors

Each of the six nominated directors of Haivision was elected as director of the Company with the following results:

Director

Votes
For

% Votes
For

Votes
Against

% Votes
Against

Miroslav Wicha

11,110,245

99.26 %

82,583

0.74 %

Harvey Bienenstock

11,155,137

99.66 %

37,691

0.34 %

Robin M. Rush

11,121,855

99.37 %

70,973

0.63 %

Neil Hindle

10,794,005

96.44 %

398,823

3.56 %

Julie Tremblay

10,941,969

97.76 %

250,859

2.24 %

Lee K. Levy II

9,084,418

81.16 %

2,108,410

18.84 %

2. Appointment of Auditors

Deloitte LLP were reappointed auditors of the Company for the ensuing year with 12,492,582 (98.84%) votes cast in favour and 146,406 (1.16%) votes withheld.

3. Approval of the Unallocated Awards under the Company’s Equity Incentive Plan

The Company’s unallocated awards were approved with 8,710,347 (77.82%) votes cast in favour and 2,482,481 (22.18%) votes cast against.

4. Reapproval of Company’s Shareholder Rights Plan

The Company’s shareholder rights plan was approved with 10,572,490 (94.46%) votes cast in favour and 620,338 (5.54%) votes cast against.

Final voting results on all matters voted on at the meeting will be filed under Haivision’s profile on SEDAR+ at www.sedarplus.ca.

About Haivision

Haivision is a leading global provider of mission-critical, real-time video streaming and visual collaboration solutions. Our connected cloud and intelligent edge technologies enable organizations globally to engage audiences, enhance collaboration, and support decision making. We provide high quality, low latency, secure, and reliable live video at a global scale. Haivision open sourced its award-winning SRT low latency video streaming protocol and founded the SRT Alliance to support its adoption. Awarded four Emmys® for Technology and Engineering from the National Academy of Television Arts and Sciences, Haivision continues to fuel the future of IP video transformation. Founded in 2004, Haivision is headquartered in Montreal and Chicago with offices, sales, and support located throughout the Americas, Europe, and Asia. Learn more at haivision.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/haivision-announces-voting-results-from-2026-annual-meeting-of-shareholders-302752318.html

SOURCE Haivision Systems Inc.